Moreover, PFKFB3 has been shown to act as a therapeutic target and participate in a variety of regulatory mechanisms in various diseases, such as cancer [54–57], pulmonary hypertension [58, 59], pulmonary fibrosis [60–62], and atherosclerosis [63, 64]. The gene discussed is PFKFB3; the disease is atherosclerosis.